DR Congo Ebola Outbreak Claims Over 4,000 Lives Amid Escalating Conflict and Aid Challenges

Published on 02/10/2026 – 18:40 GMT+2

The ongoing Ebola outbreak, first identified in mid-May, continues to devastate instability-stricken regions across the sprawling central African nation. Armed conflicts, severe resource shortages, and community mistrust have severely compromised health response efforts in recent weeks.

Official statistics confirm 4,018 deaths out of 8,300 reported cases, with 2,162 individuals having recovered, resulting in a cumulative fatality rate of 48.4%. In North Kivu province, an additional four deaths were documented among six cases in areas under the control of the Rwanda-backed M23 rebel group, as reported on Friday.

Originating in Ituri, the outbreak has now spread to seven provinces across northern and eastern Democratic Republic of Congo.

Local resistance to health measures and ongoing armed conflicts have significantly obstructed containment strategies. Violence between rival militias in Ituri has displaced over 5,000 people, according to a UN statement issued Thursday. A temporary shelter for Ebola patients was set ablaze earlier this week when military personnel entered a displacement camp, forcing residents to flee. Additionally, a case-detection contractor lost their life during an assault on a healthcare facility in North Kivu.

French Foreign Minister Jean-Noel Barrot planned a visit to Bunia, the capital of Ituri, on Friday to express France’s support for local authorities and aid workers. While no new humanitarian assistance has been announced, France previously contributed €13.4 million toward combating the outbreak between January and July.

The United States has recently approved an additional €237 million to help curb further transmission of the virus.

Frontline medical professionals face heightened exposure risks, particularly in underserved rural areas where healthcare systems remain fragile.

Clinical trials are currently underway for multiple vaccines and treatments targeting the Bundibugyo strain responsible for this outbreak. Recently, initial doses of the Ervebo vaccine—previously proven effective against the more prevalent Zaire strain—were administered to volunteer healthcare workers as part of a trial program.

Source link